CRBP - Corbus Pharmaceuticals Holdings, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue-2,440.1951,911.424648.382
Cost of Revenue-26,038.96515,436.7355,888.659
Gross Profit--23,598.77-13,525.311-5,240.277
Operating Expenses
Research Development----
Selling General and Administrative-8,964.0466,459.7473,613.416
Non Recurring----
Others----
Total Operating Expenses-35,003.01121,896.4829,502.075
Operating Income or Loss--32,562.816-19,985.058-8,853.693
Income from Continuing Operations
Total Other Income/Expenses Net-141.204-13.6172.954
Earnings Before Interest and Taxes--32,562.816-19,985.058-8,853.693
Interest Expense--14.087-4.401-2.44
Income Before Tax--32,421.612-19,998.675-8,850.739
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops--32,421.612-19,998.675-8,850.739
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income--32,421.612-19,998.675-8,850.739
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares--32,421.612-19,998.675-8,850.739